Overview

The actively managed fund is focused on capturing growth and income opportunities predominantly from Europe.

It invests predominantly in European equities, high yield corporate bonds and convertible bonds.

Each asset class weighting is kept at approximately one third.

The portfolio manager is not tied to the benchmark in terms of investment selection or weight.

Benefits

Equities, high yield corporate bonds and convertible bonds offer a compelling combination of growth and income opportunities with favorable risk/return characteristics.

Diversification across each asset class at approximately one third reduces overall risk.

Managed by a dedicated team of experts who can draw upon UBS SA国际传谋's experienced European investment teams.

Risks

This fund value may fluctuate given its equity exposure and is also impacted by changes in interest rates due to its fixed income holdings. The fund focuses intentionally on European assets, which may entail additional risks and volatility. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.This share class (mdist) may make monthly, gross-of-fee distributions. As a consequence, in addition to income, this share class may also distribute capital. This can have negative tax consequences for investors in some jurisdictions. Investors should seek their own tax advice.

Features

Asset class
UBS Asset Allocation Funds
UBS European Growth and Income Fund
Product domicile
Luxembourg
Portfolio management
UBS SA国际传谋 (UK) Ltd., London
Fund management
UBS SA国际传谋 (Europe) S.A., Luxembourg
Custodian bank
UBS Europe SE, Luxembourg Branch
Representative for products established under foreign law
UBS SA国际传谋 (Singapore) Ltd.
Day of inception
22 August, 2014
Currency of account
USD
Close of financial year
30 September
SFDR Classification
Art.6
Issue / redemption
daily
Maturity
Open end
Ongoing costs p.a.
1.82% p.a.
Management fee
1.40% p.a.
Total expense ratio (TER)
1.82% p.a.
Swing pricing
yes
Minimum investment
n.a.
Reference Index / Benchmark
Customized Benchmark
ISIN
LU1046463011
Bloomberg Ticker
UEGIPHU LX

Performance and Prices

Percentage growth

as of 22 April, 2026
Cumulative
USD(%)
YTD
1M
3M
6M
1Y 17.68
2Y
3Y 36.83
5Y 33.48
ø p.a.5Y 5.95

Current data

Net asset value 22.04.2026 USD 113.80
High - last 12 months 26.02.2026 USD 115.95
Low - last 12 months 24.04.2025 USD 103.42
Last distribution 20.04.2026 USD 0.51
Assets of the unit class in mn 22.04.2026 USD 15.66
Assets under management 22.04.2026 USD 468.02
Indicative equity dividend yield (gross) 31.03.2026 3.15%

Structures

By the 10 largest equity positions (in %, as of 31 March, 2026)

 
 
ASML HOLDING NV 0.76
DEUTSCHE TELEKOM AG 0.66
NOVARTIS AG 0.65
ASTRAZENECA PLC 0.63
SHELL PLC 0.61

By the 10 largest positions (in %, as of 31 March, 2026)

 
 
UBS Lux Bond Fund - Convert Europe EUR 19.25
UBS Lux Key Selection Sicav - European Equity Value Opportunity 14.60
UBS Lux Bond SICAV - Convert Global EUR 14.49
UBS Lux Equity SICAV - European Opportunity Unconstrained EUR 14.12
UBS Lux Equity SICAV - European High Dividend EUR 5.21
Nidda Healthcare Holding GmbH 1.10
Teva Pharmaceutical Finance Netherlands II BV 1.02
Aroundtown Finance Sarl 0.78
ZF Europe Finance BV 0.73
Pinnacle Bidco PLC 0.60

Fees

Ongoing costs p.a.
1.82%
Flat fee
1.75%
Management fee p.a.
1.40%
Max sales charge
6.00%
Max. redemption commission
0.00%
Distribution fee
(see info)

Distributions

From
01-Nov-2020
To
01-Nov-2021
Date of distribution
Pay date
Currency
Distribution
Ex-date
15.05.2025 20.05.2025 128 USD 0.48 16.06.2025 20.06.2025 129 USD 0.50 15.07.2025 18.07.2025 130 USD 0.49 18.08.2025 21.08.2025 131 USD 0.50 15.09.2025 18.09.2025 132 USD 0.50 15.10.2025 20.10.2025 133 USD 0.50 17.11.2025 20.11.2025 134 USD 0.51 15.12.2025 18.12.2025 135 USD 0.51 15.01.2026 20.01.2026 136 USD 0.51 13.02.2026 18.02.2026 137 USD 0.52 16.03.2026 19.03.2026 138 USD 0.54 15.04.2026 20.04.2026 139 USD 0.51

Sales Authorisations

Market
Sales authorisations status
Australia
Institutional Only*
Hong Kong
Registered
Luxembourg
Registered
Macau
Registered
Singapore
Registered
Switzerland
Registered

Literature

Brochures
Document type
Document Language
Fact Sheet
Fact Sheet - UBS Asset Allocation Funds
Fact Sheet - UBS European Growth and Income Fund
Agreement / Prospectus
Document type
Document Language
Prospectus
Product Highlight Sheet
Document type
Document Language
Product Highlight Sheet
Annual and semi-annual report (accounting on 30 September)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.